Harnessing the Power of Neusilin® in HPMC Matrix Tablets
![Harnessing the Power of Neusilin in HPMC Matrix Tablets](https://www.pharmaexcipients.com/wp-content/uploads/2024/09/Harnessing-the-Power-of-Neusilin-in-HPMC-Matrix-Tablets_Title.jpg)
OVERVIEW
![Harnessing the Power of Neusilin® in HPMC Matrix Tablets](https://www.pharmaexcipients.com/wp-content/uploads/2024/09/OVERVIEW-179x300.jpg)
Hydrophilic matrices, particularly those formulated with hypromellose (HPMC), are essential for controlled drug release in pharmaceutical formulations. While HPMC offers numerous advantages, its propensity to exhibit a burst release effect remains a significant challenge.
While this can be beneficial in certain cases, it often leads to suboptimal therapeutic outcomes and increased adverse effects. To ensure consistent drug delivery and optimize therapeutic efficacy, minimizing initial burst release is crucial in controlled-release formulations. Traditional excipients like microcrystalline cellulose (MCC) have been employed to mitigate this effect, but the pursuit of novel excipients with superior properties for controlled drug release continues.
NEUSILIN®: THE GAME-CHANGER
Neusilin®, an amorphous magnesium aluminometasilicate, has gained prominence as a versatile excipient in pharmaceutical formulations. Its distinctive characteristics, including a high specific surface area and adsorption capacity, make it well-suited for modulating drug release profiles.
A recent study by Bilik et al., featured in this newsletter, elucidated the effectiveness of incorporating Neusilin® into HPMC matrix tablets. The inclusion of Neusilin® significantly reduced the initial burst release of soluble drugs, such as caffeine, providing a more controlled and sustained release profile from matrices with 10-20% of HPMC content.
OPTIMIZATION OF POWDER BLENDS FOR TABLET PRODUCTION
- Mixing and Characterization
- All ingredients, as specified in Table 1, were thoroughly mixed using a three-axial homogenizer
turbula for 10 minutes. - Prior to tablet preparation, the powder blends were characterized for their flow properties.
- All ingredients, as specified in Table 1, were thoroughly mixed using a three-axial homogenizer
- Tablet Preparation
- Convex-faced HPMC matrices were directly compressed using an eccentric tablet press to achieve maximum hardness.
- Evaluation
- The prepared tablets were subjected to a comprehensive evaluation, including assessments of weight, content uniformity, hardness, friability and dissolution
- Dissolution studies were conducted to assess the rate and extent of drug release from the tablets.
TABLE 1: MATRIX TABLETS COMPOSITION *
![*Each sample contains 0.5% of Aerosil® 200 and 2.5% of magnesium stearate for better flowability and compression feasibility. ** HPMC amount always corresponds to 150 minus the numeric value or the sum ofthe numeric values in the sample designation.](https://www.pharmaexcipients.com/wp-content/uploads/2024/09/123_Fuji-1024x429.jpg)
IMPACT OF NEUSILIN®
NEUSILIN® US2 ON TABLET FORMULATION AND MECHANICAL PROPERTIES
Enhanced Tablet Hardness and Compressibility: Neusilin® US2,
![NEUSILIN® US2 ON TABLET FORMULATIONAND MECHANICAL PROPERTIES](https://www.pharmaexcipients.com/wp-content/uploads/2024/09/NEUSILIN®-US2-ON-TABLET-FORMULATION-300x295.jpg)
when incorporated as a filler, significantly improved the mechanical properties of the tablets. This was manifested by enhanced tablet hardness and excellent compression characteristics.
NEUSILIN® ON THE FORMATION OF HPMC GEL LAYER
Neusilin® matrices formed thicker gel layers than MCC matrices but required less penetration force
due to Neusilin®’s higher adsorption capacity, which allowed for deeper penetration of the dissolution medium
and promoted HPMC swelling. However, individual Neusilin® particles disrupted the gel layer more significantly than MCC alone or Neusilin® / MCC combinations, leading to faster drug release. This is depicted in figure no. 2.
![Figure 1: SEM surface topography of the selected samples of matrix tablets: (A) N75M50, (B) M125, (C) N125](https://www.pharmaexcipients.com/wp-content/uploads/2024/09/sem-1024x372.jpg)
SEM analysis revealed a more compact surface structure for sample N75M25 compared to the furrowed surfaces of samples M125 and N125.
THE FORMATION OF HPMC GEL LAYER
![Figure 2: The gel layer thickness of the HPMC matrix tablets](https://www.pharmaexcipients.com/wp-content/uploads/2024/09/Figure-2-The-gel-layer-thickness-of-the-HPMC-matrix-tablets-287x300.jpg)
![Figure 3: Cryo-SEM images showing gel layer of swollen tablet samples in the 30th min of the dissolution test: (A) M100,(B) N100, (C) M50N50.](https://www.pharmaexcipients.com/wp-content/uploads/2024/09/Figure-3-Cryo-SEM-1024x270.jpg)
Continue reading and see the full Pharmaceutical Technical Newsletter on “Harnessing the Power of Neusilin in HPMC Matrix Tablets” here:
(click the picture to download the technical newsletter)
Source: Fuji Chemical Industries technical newsletters “Harnessing the Power of Neusilin® in HPMC Matrix Tablets”
Read also other Technical Newsletter of Fuji Chemical Industries here:
- Issue 06 – The Cost-Effective Solution For Producing High-Quality Orally Disintegrating Tablets (ODTs)
- Issue 07 – Unveiling Neusilin US2´s Prowness
- Special Issue – The Potential for a Ban on TiO2 (E171) use in Pharmaceuticals
- Special Issue – pH Independent Bi-layer Self-microemulsifying Tablets (SMETs) of Candesartan Cilexetil with Fujicalin® and Neusilin®